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Members of the Kablar Lab employ a holistic approach that considers
both, the mechanical influences from the environment to the developing
lung (an ecological developmental biology approach) and, the molecular
players thatmay be involved in the transduction of themechanical signals
from the respiratorymusculature (e.g., stretch) to the alveolar epithelium.
To that end, we describe the lung phenotype of Satb1−/− mice
(Dr. Terumi Kohwi-Shigematsu) and Myb−/− mice (Dr. Jonathan
Frampton). In both mouse nulls, the lung displays most of the criteria for
the pulmonary hypoplasia. In addition, Satb1−/−mice have significantly
decreased number of type I pneumocytes, suggesting a role for Satb1 in
the type II-to-I transition. Our preliminary data suggest that CTGF is an
important player in the human lungs as well.
This work is funded by NSERC, CFI and DMRF to B.K.
doi:10.1016/j.ydbio.2010.05.480
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Gene regulation of developmental hemoglobin switching may
provide phenotypic cures for beta thalassemias and sickle cell disease
since it has been shown that reactivation of fetal globin expression
alleviates both disorders. We have discovered a protein that regulates
this developmental switch. Ferritin heavy chain (FtH) represses adult
β-globin expression and activates γ (fetal)-globin gene expression in
embryonic/K562 erythroid cells (Broyles et al., PNAS 98: 9145, 2001),
leading us to propose utilizing FtH as a therapeutic agent. FtH localizes
to the nucleus in K562 cells and represses the human adult β-globin
promoter in transient expression assays. ChIP assays using anti-FtH
polyclonal antisera show that FtH is bound to a −150 promoter
repression site in vivo in K562 cells in which the β-globin gene is
repressed. An Alexa488-tagged antisense oligonucleotide to
FtH transfected into K562 cells enters the nucleus and derepresses the
β-globin gene. Strikingly, the anti-FtHoligo knocks downboth FtHandγ
(fetal)-globin gene expression by 90%, confirming FtH's role as an
activator of fetal Hb. An FtH transgenic mouse which expresses human
FtH indefinitive erythroid cells producesmicebornwith reduced adultβ
globin. Recentexperiments showthat FtH activatesγ (fetal)-globin gene
expression, aswell as repressesβS-globin, inmaturing human erythroid
precursor cells from pediatric sickle cell patients.
This study is supported in part by donations to The Sickle Cell Cure
Foundation.
doi:10.1016/j.ydbio.2010.05.481
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Rhabdomyosarcomas (RMS) are a pediatric solid tumor of skeletal
muscle. RMS resemble cells that have committed to themyogenic lineage,
but have not yet completed differentiation. RMS fail to differentiate even
though they express the myogenic bHLH (basic helix–loop–helix)
transcription factor MyoD, a factor sufficient to induce myogenic
differentiation in multiple other cell types. The seeming paradox of
MyoD's presencebut the failure todifferentiate ledus to look formyogenic
inhibitors in RMS. We have identified two bHLH factors that had
previously been unknown to contribute to the undifferentiated RMS
state:MSC (musculin/MyoR) andE2A-2/5 (a shortened splice formof the
bHLH factor E2A). Both of these factors compete with MyoD activity in
RMS and are present in normal, undifferentiated myoblasts. Remarkably,
expression of a forced protein dimer of MyoD and full-length E2A
(MyoD∼E) differentiates a cell culture model of RMS and leads to the
downregulation of numerous myogenic inhibitors, MSC and E2A-2/5
among them. This suggests that RMS represent an arrested state of normal
myogenic development. MyoD∼E induces expression of the myogenic
microRNAs,miR-206 andmiR-133b, andmiR-206 is also sufficient to drive
RMS differentiation in cell culture. Chromatin immunoprecipitation has
identifiedMSCas binding toDNAupstreamofmiR-206 inRMS, suggesting
that competition between activating and inhibitory bHLH proteins
maintains the undifferentiated state of rhabdomyosarcomas.
doi:10.1016/j.ydbio.2010.05.482
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